Contineum Therapeutics, Inc To Start Trading Tomorrow

Contineum Therapeutics, Inc CTNM IPO will take place April, 05 on the NASDAQ exchange under the ticker CTNM.

The company is offering shares at an expected price between $16.00 and $18.00 per share with an insider lock-up period of 180 days ending on October 02, 2024.

See also: Benzinga IPO Calendar

About Contineum Therapeutics, Inc

Contineum Therapeutics, Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies that target biological pathways associated with specific clinical impairments for the treatment of NI&I indications with high unmet need.

See also: Benzinga's Most Shorted Stocks

This article was generated by Benzinga's automated content engine and reviewed by an editor.